WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
1. (WO2002087540) ARTIFICIAL BLOOD MADE OF HEMOGLOBIN ENCAPSULATED IN LIPOSOMES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/087540    International Application No.:    PCT/HU2002/000030
Publication Date: 07.11.2002 International Filing Date: 10.04.2002
IPC:
A61K 38/42 (2006.01), A61K 9/00 (2006.01), A61K 9/127 (2006.01), C07K 14/805 (2006.01)
Applicants: HORVÁTH, István [HU/HU]; (HU)
Inventors: HORVÁTH, István; (HU)
Agent: VARGA, Tamás Péter; Bertalan L. u. 20. fsz. 3/A. H-1111 Budapest (HU)
Priority Data:
P0101713 27.04.2001 HU
Title (EN) ARTIFICIAL BLOOD MADE OF HEMOGLOBIN ENCAPSULATED IN LIPOSOMES
(FR) SANG ARTIFICIEL OBTENU A PARTIR D'HEMOGLOBINE ENCAPSULEE DANS DES LIPOSOMES
Abstract: front page image
(EN)The subject of the invention relates to a process for producing artificial blood, using haemoglobin lyophilized or obtained from fresh blood, suitable for supplying blood temporarily for an organism of any blood group drained of blood. The invention relates to a process producing artificial blood suitable for supplying blood temporarily for an organism of any blood group drained of blood. The process is suitable for producing liposomes suitable to be used as artificial blood made from haemoglobin and from lipoids in organisms of vertebrata. The particles of smaller size than genuine blood-cells (200-500nm) are suitable for substituting the function of gas supply of red blood-cells. Production of artificial blood particles can take place with using haemoglobin of congener or foreign type.
(FR)Cette invention concerne un procédé permettant de produire du sang artificiel à partir d'hémoglobine lyophilisée tirée de sang frais, lequel sang artificiel peut alimenter temporairement un organisme indépendamment de son groupe sanguin. Le procédé permet de produire des liposomes destinés à être utilisés comme sang artificiel obtenu à partir d'hémoglobine et de lipoïdes dans des organismes de vertébrés. Les particules de ce sang artificiel, dont la taille est inférieure à celle des globules sanguins (200-500nm) assurent la fonction de fixation gazeuse dévolue aux globules rouges. Pour la production de particules de sang artificiel, on peut utiliser de l'hémoglobine de type congénère ou étranger.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)